Clinical Trial Update: Antibodies and Liver Retransplantation

View source ↗

Summary

A clinical trial update concerning the use of antibodies in liver retransplantation for liver transplant failure and antibody-mediated rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection
• Liver Transplant Failure

Snippet

Sponsor: London Health Sciences Centre | Conditions: Liver Transplant Failure, Antibody-mediated Rejection | Status: UNKNOWN